Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksARDN.L Regulatory News (ARDN)

  • There is currently no data for ARDN

Correction : Form 8.3 - Arden Partners Plc

28 Oct 2021 16:45

Premier Miton Group Plc - Correction : Form 8.3 - Arden Partners Plc

Premier Miton Group Plc - Correction : Form 8.3 - Arden Partners Plc

PR Newswire

London, October 28

Two errors have been corrected;2 a) the holding has been recalculated on the correct denominator655,476 2.25449%3 a) sales corrected

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:PREMIER MITON GROUP PLC
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeArden Partners plc
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
(e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure27/10/2021
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A” N/A If YES, specify which:

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:Ords
InterestsShort positions
Number%Number%
(1) Relevant securities owned and/or controlled:655,4762.25449%
(2) Cash-settled derivatives:
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:
TOTAL:655,4762.25449%

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:n/a
Details, including nature of the rights concerned and relevant percentages:n/a

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant securityPurchase/saleNumber of securitiesPrice per unit
OrdinarySale250,00025
OrdinarySale100,00025.5

(b) Cash-settled derivative transactions

Class of relevant securityProduct description e.g. CFDNature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit
n/a

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitType e.g. American, European etc.Expiry dateOption money paid/ received per unit
n/a

(ii) Exercise

Class of relevant securityProduct description e.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit
n/a

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealing e.g. subscription, conversionDetailsPrice per unit (if applicable)
n/a

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none”
None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?NO

Date of disclosure:28/10/2021
Contact name:Claire Brightman
Telephone number:01483 400432

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Date   Source Headline
11th Mar 202112:30 pmRNSDirector/PDMR Shareholding
11th Mar 202110:55 amRNSHolding(s) in Company
3rd Mar 20218:53 amRNSShare Purchase By Employee Benefit Trust
2nd Mar 20214:11 pmRNSGrant of Options
2nd Mar 202110:21 amRNSShare Purchase by Employee Benefit Trust
18th Feb 20213:38 pmRNSPublication of Annual Report and Notice of AGM
17th Feb 202110:55 amRNSShare Purchase By Employee Benefit Trust
16th Feb 20217:00 amRNSAudited Results For The Year Ended 31 October 2020
11th Feb 20211:17 pmRNSDirector/PDMR Shareholding
12th Jan 20212:27 pmRNSDirector/PDMR Shareholding
11th Dec 202012:54 pmRNSDirector/PDMR Shareholding
11th Nov 20203:13 pmRNSTransaction in Own Shares
27th Oct 20209:43 amRNSShare Purchase by Employee Benefit Trust
13th Oct 202010:39 amRNSDirector/PDMR Shareholding
8th Oct 20209:43 amRNSShare Purchase by Employee Benefit Trust
17th Sep 202011:25 amRNSShare Purchase by Employee Benefit Trust
11th Sep 20208:43 amRNSDirector/PDMR Shareholding
7th Sep 202011:04 amRNSShare Purchase by Employee Benefit Trust
4th Sep 202011:57 amRNSShare Purchase by Employee Benefit Trust
11th Aug 20203:43 pmRNSDirector/PDMR Shareholding
11th Aug 20209:15 amRNSShare Purchase by Employee Benefit Trust
29th Jul 20209:05 amRNSShare Purchase by EBT and Holdings in Company
27th Jul 20207:00 amRNSInterim Results - Six Months Ended 30th April 2020
14th Jul 20209:56 amRNSDirector/PDMR Shareholding
9th Jul 20208:38 amRNSHolding(s) in Company
26th Jun 20209:08 amRNSShare Purchase By Employee Benefit Trust
11th Jun 20203:31 pmRNSDirector/PDMR Shareholding
11th Jun 20209:02 amRNSShare Purchase by Employee Benefit Trust
26th May 202011:00 amRNSHolding(s) in Company
26th May 202011:00 amRNSHolding(s) in Company
26th May 202010:58 amRNSDirector/PDMR Shareholding
26th May 20207:00 amRNSEmployee Incentivisation
21st May 20209:50 amRNSShare Purchase by Employee Benefit Trust
19th May 20207:00 amRNSHolding(s) in Company
12th May 20201:36 pmRNSDirector/PDMR Shareholding
1st May 20207:00 amRNSTrading Update
24th Apr 202010:28 amRNSHolding(s) in Company
15th Apr 202012:24 pmRNSDirector/PDMR Shareholding
8th Apr 20208:43 amRNSHolding(s) in Company
30th Mar 202011:55 amRNSForm 8.5 (EPT/NON-RI)
25th Mar 20202:39 pmRNSResult of AGM
20th Mar 20207:00 amRNSStatement Re AGM and Change of Venue
19th Mar 20207:00 amRNSStatement Regarding Share Price Movement
11th Mar 20201:19 pmRNSDirector/PDMR Shareholding
18th Feb 20202:26 pmRNSPublication of Annual Report and Notice of AGM
11th Feb 20202:10 pmRNSDirector/PDMR Shareholding
3rd Feb 20207:00 amRNSPreliminary Results - Year Ended 31 October 2019
13th Jan 20201:51 pmRNSDirector/PDMR Shareholding
2nd Jan 202011:55 amRNSForm 8.5 (EPT/NON-RI)
31st Dec 201911:00 amRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.